Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.408NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.256NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.256NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.7 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.7 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.460NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.460NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.262NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.262NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.43.6 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.43.6 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBF.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBF.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.43.9 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.43.9 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XUNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XUNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.144NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.144NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.288NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.288NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.249NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.249NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.378NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.378NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.97NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.97NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.1.6.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.1.6.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.4.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.4.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FQ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FQ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21359South Korea
JB.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JB.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.3.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.3.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.3 (Omicron)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.3 (Omicron)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.16.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.16.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.372NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used